Strategic Evaluation of Precision Medicine: Country Analysis for Emerging Opportunities, 2017-2020 - ResearchAndMarkets.com

September 18, 2018

DUBLIN--(BUSINESS WIRE)--Sep 18, 2018--The “Strategic Evaluation of Precision Medicine: Country Analysis for Emerging Opportunities” report has been added to ResearchAndMarkets.com’s offering.

In 2017, the global precision medicine market accounted for $48.9 billion, which is expected to reach $70 billion by 2020 with effective implementation of several novel technologies. Further, several initiatives have been undertaken for significant growth of precision medicine in North America, Europe, and Asia-Pacific. The global precision medicine market is dominated by the North America region with a value of $25.6 billion in 2017.

The precision medicine market, cumulative of biopharmaceuticals, diagnostics, and information technology, is fragmented in nature due to the involvement of numerous global as well as regional players in this industry. Also, many regulatory bodies and consortiums are playing vital roles in regulating and standardizing the precision medicine market.

The promotion of big data analytics to support the process of genomic and clinical data collection, storage, and analysis is leading to increasing integration of IT into the healthcare sector, subsequently enhancing the adoption of precision medicine tools. However, the Asia-Pacific region has been witnessing tremendous growth in the precision medicine technology and is expected to grow significantly at a CAGR of approximately 15.09% in the next 10 years.

Additionally, the study incorporates the impact of various government initiatives focused on precision medicine including Small Business Technology Transfer (STTR), Cancer Diagnosis Program, Cancer Imaging Program, Cancer Therapy Evaluation Program (CTEP), Cancer Moonshot 2020, and S4S Program, among others. These initiatives have introduced a new module of patient-centric research to provide new tools, technologies, and therapies to clinicians. Moreover, initiatives taken in Asia-Pacific region such as GenomeAsia 100K are expected to generate a medical grade Asian reference genome to further improvise precision medicine research.

Key Topics Covered:

1 Precision Medicine: A Frontier in the Genesis of Patient-centric Medicine

1.1 Precision Medicine: Remodelling the One-Size-Fits-All Theory to Individually-Tailored Therapy

2 Regional Strategy for Penetration and Implementation of Precision Medicine

2.1 North America

2.2 Europe

2.3 Asia-Pacific

3 Best Practices Across the World (U.S., U.K., and China)

4 Augmenting the Growth by Realizing the Full Potential of Precision Medicine Technologies

5 The Eminent Stakeholders Aligning the Fortune of Precision Medicine

5.1 Industrial Perspective Directing the Peaks and Valleys of Precision Medicine Market

5.2 Organizations Reducing the Disparities in Healthcare System

6 Propitious Strategies for Succeeding in the Field of Precision Medicine

6.1 Marketing and Promotion Strategies: To Provide an Edge in Highly Competitive Precision Medicine Market

7 Realizing the Impact of Precision Medicine

For more information about this report visit https://www.researchandmarkets.com/research/nxz8nq/strategic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180918005357/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/18/2018 03:59 AM/DISC: 09/18/2018 03:59 AM


Update hourly